东欧炎症性肠病的发病率和患病率在上升吗？
Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?
作者信息
Lakatos L, Lakatos P L
机构信息
1st Department of Medicine, Csolnoky F Province Hospital, Veszprem, Hungary.
出版信息
Postgrad Med J. 2006 May;82(967):332-7. doi: 10.1136/pgmj.2005.042416.
Abstract
Limited data are available on the frequency of inflammatory bowel diseases in East European countries. A recent study from Hungary reported an increasing incidence rate for ulcerative colitis (from 1.6 to 11.0) and for Crohn's disease (from 0.4 to 4.7) from 1977 to 2001. A similar trend was seen in Croatia. In contrast, other countries (for example, Czech Republic, Poland, Romania, Slovakia, and Baltic countries) reported low incidence and prevalence rates. This review will discuss the available data on the epidemiology of inflammatory bowel diseases in Eastern Europe, as well as consider the possible factors responsible for the differences seen between countries and epidemiological trends.
摘要
关于东欧国家炎症性肠病的发病率，现有数据有限。匈牙利最近的一项研究报告称，1977年至2001年期间，溃疡性结肠炎的发病率（从1.6增至11.0）和克罗恩病的发病率（从0.4增至4.7）均呈上升趋势。克罗地亚也出现了类似趋势。相比之下，其他国家（如捷克共和国、波兰、罗马尼亚、斯洛伐克和波罗的海国家）报告的发病率和患病率较低。本综述将讨论东欧炎症性肠病流行病学的现有数据，并探讨造成各国之间差异及流行病学趋势的可能因素。
相似文献
1
Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?东欧炎症性肠病的发病率和患病率在上升吗？
Postgrad Med J. 2006 May;82(967):332-7. doi: 10.1136/pgmj.2005.042416.
2
Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.炎症性肠病的生物治疗：中东欧地区的可及性
World J Gastroenterol. 2015 Feb 14;21(6):1728-37. doi: 10.3748/wjg.v21.i6.1728.
3
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.欧洲炎症性肠病发病率的东西梯度：ECCO-EpiCom 起始队列。
Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.
4
5
Tuberculosis trends in eastern Europe and the former USSR.东欧及前苏联地区的结核病趋势
Tuber Lung Dis. 1994 Dec;75(6):400-16. doi: 10.1016/0962-8479(94)90113-9.
6
[Epidemiology and risk factors of inflammatory bowel diseases].[炎症性肠病的流行病学及危险因素]
Bull Acad Natl Med. 2007 Jun;191(6):1105-18; discussion 1118-23.
7
Cancer epidemiology in Central, South and Eastern European countries.中东欧和东南欧国家的癌症流行病学
Croat Med J. 2011 Aug 15;52(4):478-87. doi: 10.3325/cmj.2011.52.478.
8
Region-specific differences in colorectal cancer: Slovakia and Hungary have highest incidence in Europe.结直肠癌的地区差异：斯洛伐克和匈牙利在欧洲发病率最高。
Bratisl Lek Listy. 2016;117(2):66-71. doi: 10.4149/bll_2016_013.
9
The analysis of tobacco consumption in Croatia--are we successfully facing the epidemic?克罗地亚烟草消费分析——我们是否成功应对了这一流行病？
Cent Eur J Public Health. 2012 Mar;20(1):5-10. doi: 10.21101/cejph.a3702.
10
New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe.东欧炎症性肠病流行病学和疾病进程的新趋势。
Dig Liver Dis. 2013 Apr;45(4):269-76. doi: 10.1016/j.dld.2012.08.020. Epub 2012 Sep 24.
引用本文的文献
1
Latin America consensus statement inflammatory bowel disease: importance of timely access to diagnosis and treatment.拉丁美洲炎症性肠病共识声明：及时获得诊断和治疗的重要性。
Therap Adv Gastroenterol. 2023 Dec 23;16:17562848231207312. doi: 10.1177/17562848231207312. eCollection 2023.
2
Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults.来自加拿大西部一个省份的基于人群的证据：成人炎症性肠病发病率下降及趋势
J Can Assoc Gastroenterol. 2020 Aug 21;4(4):186-193. doi: 10.1093/jcag/gwaa028. eCollection 2021 Aug.
3
Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases.吸烟对炎症性肠病患者骨质疏松风险的影响。
J Clin Med. 2021 Apr 5;10(7):1515. doi: 10.3390/jcm10071515.
4
The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease.克罗恩病患者中肌肉减少症的患病率及其对预后的影响。
Intest Res. 2020 Jan;18(1):79-84. doi: 10.5217/ir.2019.00107. Epub 2020 Jan 30.
5
Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East.伊朗克罗恩病和结肠炎登记处：中东首个全国性炎症性肠病登记处的研究概况
Intest Res. 2019 Jul;17(3):330-339. doi: 10.5217/ir.2018.00157. Epub 2019 Apr 24.
6
Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015.捷克儿童炎症性肠病发病率：一项2000 - 2015年的区域前瞻性研究
World J Gastroenterol. 2017 Jun 14;23(22):4090-4101. doi: 10.3748/wjg.v23.i22.4090.
7
5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.负载5-氨基水杨酸的二氧化硅纳米颗粒——一种针对小鼠溃疡性结肠炎的新型靶向治疗给药系统。
Mol Med Rep. 2017 Mar;15(3):1117-1122. doi: 10.3892/mmr.2017.6153. Epub 2017 Jan 26.
8
Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-κB signaling and T-helper cell homeostasis.去亚甲基小檗碱通过调节 NF-κB 信号通路和辅助性 T 细胞稳态缓解小鼠的炎症性肠病。
Inflamm Res. 2017 Feb;66(2):187-196. doi: 10.1007/s00011-016-1005-3. Epub 2016 Nov 29.
9
Ulcerative Colitis and Its Association with Salmonella Species.溃疡性结肠炎及其与沙门氏菌属的关联。
Interdiscip Perspect Infect Dis. 2016;2016:5854285. doi: 10.1155/2016/5854285. Epub 2016 Jan 20.
10
Expression of Beclin1 in the colonic mucosa tissues of patients with ulcerative colitis.自噬相关基因Beclin1在溃疡性结肠炎患者结肠黏膜组织中的表达
Int J Clin Exp Med. 2015 Nov 15;8(11):21098-105. eCollection 2015.
本文引用的文献
1
Inflammatory bowel disease in the Hubei Province of China.中国湖北省的炎症性肠病。
World J Gastroenterol. 1997 Jun 15;3(2):119-20. doi: 10.3748/wjg.v3.i2.119.
2
Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study.2000 - 2004年克罗地亚滨海和山区县炎症性肠病的发病率：一项基于人群的前瞻性研究。
Scand J Gastroenterol. 2006 Apr;41(4):437-44. doi: 10.1080/00365520500320094.
3
Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery.克罗恩病的临床表现。家族性疾病、吸烟、疾病表型、肠外表现与手术需求之间的关联。
Hepatogastroenterology. 2005 May-Jun;52(63):817-22.
4
Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.波兰东北部炎症性肠病的流行病学特征
World J Gastroenterol. 2005 May 7;11(17):2630-3. doi: 10.3748/wjg.v11.i17.2630.
5
Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study.罗马尼亚接受胃肠病护理的成年炎症性肠病流行病学：一项多中心研究。
Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1153-9. doi: 10.1097/00042737-200411000-00012.
6
Clinical relevance of advances in genetics and pharmacogenetics of IBD.炎症性肠病遗传学和药物遗传学进展的临床相关性
Gastroenterology. 2004 May;126(6):1533-49. doi: 10.1053/j.gastro.2004.01.061.
7
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999).法国北部克罗恩病和溃疡性结肠炎发病率的相反演变（1988 - 1999年）
Gut. 2004 Jun;53(6):843-8. doi: 10.1136/gut.2003.025346.
8
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.1977年至2001年间，匈牙利西部某省炎症性肠病的发病率和患病率显著上升。
World J Gastroenterol. 2004 Feb 1;10(3):404-9. doi: 10.3748/wjg.v10.i3.404.
9
Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England.炎症性肠病的患病率及管理：一项来自英格兰中部的横断面研究
Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1275-80. doi: 10.1097/00042737-200312000-00004.
10
[Etiopathogenesis of inflammatory bowel diseases].[炎症性肠病的病因发病机制]
Orv Hetil. 2003 Sep 21;144(38):1853-60.
Zotero 插件